We are live on ! Find out more
MP

Mangrove Partners Portfolio holdings

AUM $1.24B
1-Year Est. Return 41.74%
This Fund
S&P 500
This Quarter Est. Return
-27.66%
1 Year Est. Return
+41.74%
3 Year Est. Return
+169.22%
5 Year Est. Return
+150.23%
10 Year Est. Return
+417.9%
AUM
$725M
AUM Growth
+$41.8M
Cap. Flow
+$440M
Cap. Flow %
60.69%
Top 10 Hldgs %
66.05%
Holding
87
New
15
Increased
15
Reduced
12
Closed
10

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$292M
2
PCG icon
PG&E
PCG
+$43M
3
SMCI icon
Super Micro Computer
SMCI
+$33.7M
4
CCXI
ChemoCentryx, Inc.
CCXI
+$24.9M
5
TGTX icon
TG Therapeutics
TGTX
+$15.7M

Top Sells

Rank Stock Value
1
NIHD
NII Holdings, Inc. Common Stock
NIHD
+$17.8M
2
IOVA icon
Iovance Biotherapeutics
IOVA
+$7.83M
3
FOMX
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
+$5.93M
4
PDCE
PDC Energy, Inc.
PDCE
+$5.77M
5
GYRE icon
Gyre Therapeutics
GYRE
+$4.65M

Sector Composition

Rank Sector Weight
1 Healthcare 16.73%
2 Energy 8.12%
3 Communication Services 7.53%
4 Materials 5.91%
5 Industrials 4.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FLY
26
DELISTED
Fly Leasing Limited
FLY
$5.77M 0.8%
819,198
+68,260
+9% +$1.05M
ROCC
27
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
$5.34M 0.74%
1,729,382
– –
BLU
28
DELISTED
BELLUS Health Inc.
BLU
$5.13M 0.71%
513,684
+77,499
+18% +$691K
EIGR
29
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$4.65M 0.64%
22,794
-5,449
-19% -$1.74M
GLRE icon
30
Greenlight Captial
GLRE
$586M
$4.63M 0.64%
778,918
+95,170
+14% +$819K
PDCE
31
CALL
DELISTED
PDC Energy, Inc.
PDCE
$4.35M 0.6%
700,000
– –
SRRA
32
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$4.32M 0.6%
+439,532
New +$5.76M
I
33
DELISTED
INTELSAT S. A.
I
$2.95M 0.41%
+1,930,342
New +$8.09M
VYNE icon
34
VYNE Therapeutics
VYNE
$19.1M
$2.83M 0.39%
293
+104
+55% +$1.63M
NMCI
35
DELISTED
Navios Maritime Containers L.P. Common Units
NMCI
$2.35M 0.32%
3,307,850
– –
BTU icon
36
Peabody Energy
BTU
$2.83B
$1.97M 0.27%
679,308
-245,777
-27% -$1.57M
METC icon
37
Ramaco Resources Class A
METC
$637M
$1.83M 0.25%
793,303
– –
CCO icon
38
Clear Channel Outdoor Holdings
CCO
$1.23B
$1.77M 0.24%
+2,768,281
New +$5.89M
AMR icon
39
Alpha Metallurgical Resources
AMR
$1.84B
$1.66M 0.23%
706,108
-70
-0% -$401
PCG icon
40
PUT
PG&E
PCG
$39.2B
$1.46M 0.2%
+162,800
New +$2.16M
LRMR icon
41
Larimar Therapeutics
LRMR
$398M
$1.36M 0.19%
146,902
-1,152
-0.8% -$15.1K
EGLE
42
DELISTED
Eagle Bulk Shipping Inc.
EGLE
$907K 0.13%
70,039
+25,165
+56% +$560K
CRBP icon
43
CALL
Corbus Pharmaceuticals
CRBP
$168M
$485K 0.07%
+3,083
New +$521K
CCX.WS
44
DELISTED
Churchill Capital Corp II Warrants, each exercisable for one share of Class A common stock at an exe
CCX.WS
$467K 0.06%
283,333
– –
TNK icon
45
Teekay Tankers
TNK
$2.66B
$400K 0.06%
+17,976
New +$329K
CVM icon
46
PUT
CEL-SCI Corp
CVM
$21M
$328K 0.05%
+947
New +$346K
SNDE
47
DELISTED
Sundance Energy Inc. Common Stock
SNDE
$275K 0.04%
121,199
+1
+0% +$9
CFFAW
48
DELISTED
CF Finance Acquisition Corp. Warrant
CFFAW
$263K 0.04%
525,000
– –
DMYT.U
49
DELISTED
dMY Technology Group, Inc. Units, each consisting of one share of Class A Common Stock and one-half
DMYT.U
$246K 0.03%
+25,000
New +$250K
HYACW
50
DELISTED
Haymaker Acquisition Corp. II Warrant
HYACW
$245K 0.03%
233,333
– –
1
2
3 4

Similar funds

GX
Greylock XIV Menlo Park, California $1.24B AUM
HCA
Harbor Capital Advisors Chicago, Illinois $1.23B AUM 30.56% 1-Year Est. Return
CA
Cullinan Associates Louisville, Kentucky $1.24B AUM 28.12% 1-Year Est. Return
WTA
Washington Trust Advisors Wellesley, Massachusetts $1.24B AUM 22.58% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
FLII
First Long Island Investors Jericho, New York $1.23B AUM 14.42% 1-Year Est. Return
CCA
Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Mangrove Partners's Q1 2020 Portfolio in Review

As of Q1 2020, Mangrove Partners held 87 positions worth $725M, up 6.1% from $683M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Mangrove Partners deployed $440M of net new capital in Q1 2020, opening 15 new positions and adding to 15 existing holdings. Its largest new stake was iShares Russell 2000 ETF: 1,961,000 shares worth $224M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Energy and Communication Services.

On the sell side, the largest reduction was Iovance Biotherapeutics, an estimated $7.83M trimmed.

  • Mangrove Partners's largest Q1 2020 buy was iShares Russell 2000 ETF: 1,961,000 shares worth $224M.
  • Mangrove Partners added most to PG&E in Q1 2020, an estimated $43M increase.
  • Mangrove Partners's biggest Q1 2020 reduction was Iovance Biotherapeutics, cutting an estimated $7.83M.
  • Mangrove Partners fully exited NII Holdings, Inc. Common Stock in Q1 2020, selling an estimated $17.8M.
  • Mangrove Partners's ten largest holdings make up 66% of its $725M portfolio in Q1 2020.
  • Mangrove Partners opened 15 new positions and closed 10 in Q1 2020.
  • Mangrove Partners's portfolio value rose 6.1% quarter-over-quarter to $725M.

Based on Mangrove Partners's 13F filing for Q1 2020, filed 15 May 2020.